The "Expert Consensus on Clinical Diagnosis and Treatment of Meibomian Gland Carcinoma in China (2017)" details the characteristics, staging, diagnosis, and treatment of meibomian gland carcinoma, a malignant eyelid tumor predominantly affecting individuals over 60. It highlights the risk of misdiagnosis and provides a staging system based on AJCC criteria, focusing on tumor size, lymph node involvement, and metastasis. Diagnosis involves clinical evaluation and pathology, while treatment primarily includes surgical excision, with additional therapies as needed. Regular follow-up care is recommended to monitor for recurrence and ensure patient well-being.